← 產業報告目錄

Surgical Gowns and Drapes Market by Product Type (Drapes, Gowns), Usage (Disposable, Reusable), Material [Nonwoven (PP, PE), Woven (Cotton, Polyester)], Sterility, Application (Cardiovascular, Laparoscopy, End User (Hospitals, ASCs) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-12-02頁數 379報告編號 MD6179

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global surgical gowns and drapes market is projected to reach USD 6.01 billion by 2030 from USD 4.69 billion in 2025, at a CAGR of 5.1% during the forecast period. The market is expected to experience high growth due to the rising prevalence of healthcare-associated infections (HAIs), an increase in surgical procedures, and advancements in fabric technologies. The growing focus on infection prevention and patient safety, as well as innovations in antimicrobial and fluid-resistant materials, are driving the demand for high-quality surgical gowns and drapes. However, concerns over the environmental impact of disposable products and the high cost of premium surgical textiles may restrain market growth. Nonetheless, the continuous improvement in product performance and increasing adoption in hospitals and healthcare facilities are expected to fuel the market expansion. The hospitals segment is expected to have the largest market during the forecast period. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and other end users. In 2024, hospitals accounted for the largest share of the market. The hospital segment is the largest in the surgical gowns and drapes market due to the high volume of surgeries and medical procedures performed in hospitals worldwide. Hospitals are primary settings for surgeries, where maintaining a sterile environment is critical to preventing infections and ensuring patient safety. The demand for surgical gowns and drapes in hospitals is driven by the need for high-quality, reliable infection control products to protect both patients and healthcare professionals. Additionally, hospitals are more likely to adopt advanced materials and technologies, such as fluid-resistant and antimicrobial fabrics, to enhance infection prevention. With a constant need for surgical gowns and drapes in operating rooms, patient care areas, and other clinical settings, the hospital segment remains the largest and most dominant end user in the market. The general surgery products segment accounted for the largest market share in the surgical gowns and drapes market. The surgical gowns and drapes market is segmented into general surgery, cardiovascular, gynecology, ophthalmology, lithotomy & laparoscopy, and other applications, based on application. The general surgery segment is the largest in the surgical gowns and drapes market due to the high volume of procedures performed globally. General surgeries, such as appendectomies, gallbladder removals, and hernia repairs, are among the most common medical procedures, driving significant demand for surgical gowns and drapes. These surgeries require strict infection control measures to ensure patient safety, making high-quality surgical textiles essential. The widespread use of disposable gowns and drapes in general surgery helps maintain a sterile environment, reduce the risk of infections, and enhance overall procedural efficiency. As general surgeries continue to be performed at a high rate, this segment remains the dominant driver of growth in the surgical gowns and drapes market. Asia Pacific is expected to be the fastest-growing market for surgical gowns and drapes during the forecast period. The global surgical gowns and drapes market is segmented into six segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is expected to be the fastest-growing market for surgical gowns and drapes during the forecast period. The region’s rapid urbanization, coupled with growing healthcare infrastructure, has significantly increased the demand for infection control products, including surgical gowns and drapes. As the number of surgeries rises in countries like China, India, and Southeast Asia, the need for high-quality, cost-effective surgical textiles grows. Moreover, the increasing prevalence of healthcare-associated infections (HAIs) and government initiatives aimed at improving healthcare standards are further driving the adoption of surgical gowns and drapes in the region. With a large population base and a growing focus on patient safety, the Asia Pacific is poised to experience substantial growth in this market over the coming years. North America leads the surgical gowns and drapes market in terms of market size, driven by its advanced healthcare systems and high number of surgical procedures performed annually. The region's well-established healthcare infrastructure, coupled with stringent infection control regulations, has made surgical gowns and drapes essential in maintaining sterile environments during surgeries. Additionally, North America’s focus on patient safety and the adoption of advanced fabric technologies, such as antimicrobial and fluid-resistant materials, further boost the demand for these products. The presence of leading manufacturers and significant healthcare expenditure in countries such as the US and Canada ensures that North America remains the dominant market for surgical gowns and drapes. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1: 28%, Tier 2: 42%, and Tier 3: 30% • By Designation: C Level: 30%, Director Level: 34%, and Others: 36% • By Region: North America: 51%, Europe: 21%, Asia Pacific: 18%, Latin America: 6%, and Middle East & Africa: 4% • Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The major players operating in the surgical gowns and drapes market are Cardinal Health (US), Owens & Minor (US), Medline Industries, LP. (US), McKesson Corporation (US), and Mölnlycke AB (Sweden). Research Coverage This report examines the surgical gowns and drapes market in terms of product type, material, sterility, application, end user, and regions. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets in terms of their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established firms and smaller entrants to gauge the market’s pulse, which in turn will help them garner a larger market share. Firms purchasing the report could use one or more strategies mentioned below to strengthen their market presence. This report provides insights into the following pointers: Analysis of key Drivers (Growing prevalence of HAIs, Increasing number of surgical procedures, Rising focus on infection prevention protocols, Expansion of ambulatory surgical centers) Restraints (Reuse of surgical gowns and drapes in developing regions, High cost of premium disposable products) Opportunities (Growth opportunities in emerging countries, Adoption of advanced fabric technologies) Challenges (Supply chain volatility in raw materials, Quality inconsistency among low-cost suppliers) Market Penetration: Comprehensive information on the product portfolios offered by the top players in the surgical gowns and drapes market Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the surgical gowns and drapes market Market Development: Comprehensive information on lucrative emerging regions Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the surgical gowns and drapes market Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players, such as Cardinal Health (US), Owens & Minor (US), Medline Industries, LP. (US), McKesson Corporation (US), and Mölnlycke AB (Sweden)
目錄 Table of Contents
1 INTRODUCTION 35 1.1 STUDY OBJECTIVES 35 1.2 MARKET DEFINITION 35 1.3 STUDY SCOPE 36 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 36 1.3.2 INCLUSIONS AND EXCLUSIONS 37 1.3.3 YEARS CONSIDERED 38 1.4 CURRENCY CONSIDERED 38 1.5 STAKEHOLDERS 38 1.6 SUMMARY OF CHANGES 38 2 EXECUTIVE SUMMARY 40 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 40 2.2 KEY MARKET PARTICIPANTS: INSIGHTS AND STRATEGIC DEVELOPMENTS 41 2.3 DISRUPTIVE TRENDS SHAPING MARKET 41 2.4 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS 42 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 43 3 PREMIUM INSIGHTS 44 3.1 SURGICAL GOWNS AND DRAPES MARKET OVERVIEW 44 3.2 SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2025 VS. 2030 45 3.3 SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2025 VS. 2030 45 3.4 SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2025 VS. 2030 46 3.5 SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2025 VS. 2030 46 3.6 SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2025 VS. 2030 47 3.7 SURGICAL GOWNS AND DRAPES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47 4 MARKET OVERVIEW 48 4.1 INTRODUCTION 48 4.2 MARKET DYNAMICS 48 4.2.1 DRIVERS 49 4.2.1.1 Rising prevalence of healthcare-associated infections 49 4.2.1.2 Increasing number of surgical procedures 50 4.2.1.3 Growing focus on infection prevention protocols 51 4.2.1.4 Expansion of ambulatory surgical centers 52 4.2.2 RESTRAINTS 52 4.2.2.1 Reuse of surgical gowns and drapes in developing regions 52 4.2.2.2 High cost of premium disposable products 52   4.2.3 OPPORTUNITIES 53 4.2.3.1 Growth opportunities in emerging countries 53 4.2.3.2 Adoption of advanced fabric technologies 53 4.2.4 CHALLENGES 54 4.2.4.1 Supply chain volatility in raw materials 54 4.2.4.2 Quality inconsistency among low-cost suppliers 54 4.3 UNMET NEEDS AND WHITE SPACES 55 4.3.1 UNMET NEEDS IN SURGICAL GOWNS AND DRAPES MARKET 55 4.3.2 WHITE SPACE OPPORTUNITIES 55 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 56 4.4.1 INTERCONNECTED MARKETS 56 4.4.2 CROSS-SECTOR OPPORTUNITIES 57 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 57 4.5.1 KEY MOVES AND STRATEGIC FOCUS 57 5 INDUSTRY TRENDS 59 5.1 PORTER’S FIVE FORCES ANALYSIS 59 5.1.1 THREAT OF NEW ENTRANTS 60 5.1.2 THREAT OF SUBSTITUTES 60 5.1.3 BARGAINING POWER OF BUYERS 60 5.1.4 BARGAINING POWER OF SUPPLIERS 60 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 61 5.2 MACROECONOMIC INDICATORS 61 5.2.1 INTRODUCTION 61 5.2.2 GDP TRENDS AND FORECAST 61 5.3 SUPPLY CHAIN ANALYSIS 64 5.4 VALUE CHAIN ANALYSIS 65 5.5 ECOSYSTEM ANALYSIS 67 5.6 PRICING ANALYSIS 68 5.6.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 68 5.6.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 68 5.6.3 AVERAGE SELLING PRICE TREND, BY REGION 69 5.7 TRADE ANALYSIS 70 5.7.1 IMPORT SCENARIO (HS CODE 621010) 70 5.7.2 EXPORT SCENARIO (HS CODE 621010) 71 5.8 KEY CONFERENCES AND EVENTS, 2025–2026 71 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 72 5.10 INVESTMENT AND FUNDING SCENARIO 73 5.11 CASE STUDY ANALYSIS 73 5.11.1 CASE STUDY 1: COST BENEFIT ANALYSIS OF SURGICAL GOWN AND DRAPE SELECTION 73 5.11.2 CASE STUDY 2: COMPARE IMPACT AND COST-EFFECTIVENESS LONG FIBER POLYESTER VS. COTTON FABRIC DRAPES 74 5.11.3 CASE STUDY 3: EVALUATE AND COMPARE PERFORMANCE OF DISPOSABLE VS. REUSABLE MEDICAL GOWNS 75 5.12 IMPACT OF 2025 US TARIFFS ON SURGICAL GOWNS AND DRAPES MARKET 75 5.12.1 INTRODUCTION 75 5.12.2 KEY TARIFF RATES 76 5.12.3 PRICE IMPACT ANALYSIS 77 5.12.4 KEY IMPACT ON COUNTRY/REGION 77 5.12.4.1 North America 77 5.12.4.2 Europe 77 5.12.4.3 Asia Pacific 77 5.12.5 IMPACT ON END-USE INDUSTRIES 78 5.12.5.1 Hospitals 78 5.12.5.2 Ambulatory Surgical Centers (ASCs) 78 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 79 6.1 KEY EMERGING TECHNOLOGIES 79 6.1.1 SMART TEXTILES (E-TEXTILES) 79 6.1.2 BIODEGRADABLE AND COMPOSTABLE MATERIALS 79 6.1.3 ANTIMICROBIAL AND ANTIVIRAL COATINGS 79 6.2 COMPLEMENTARY TECHNOLOGIES 80 6.2.1 STERILIZATION TECHNOLOGIES 80 6.2.2 REUSABLE SURGICAL TEXTILES 80 6.3 TECHNOLOGY/PRODUCT ROADMAP 81 6.3.1 SHORT-TERM (2025–2027) | PROCESS IMPROVEMENT & STANDARDIZATION 81 6.3.2 MID-TERM (2027–2030) | MATERIAL DIVERSIFICATION & SUSTAINABILITY 81 6.3.3 LONG-TERM (2030–2035+) | HIGH-PERFORMANCE & ECO-EFFICIENT LABWARE 82 6.4 TECHNOLOGY/PRODUCT ROADMAP 83 6.5 PATENT ANALYSIS 84 6.6 FUTURE APPLICATIONS 86 6.7 IMPACT OF AI/GENERATIVE AI ON SURGICAL GOWNS AND DRAPES MARKET 86 6.7.1 TOP USE CASES AND MARKET POTENTIAL 87 6.7.2 BEST PRACTICES IN SURGICAL GOWNS AND DRAPES MARKET 87 6.7.3 FUTURE OF AI IN SURGICAL GOWNS AND DRAPES MARKET 88   7 SUSTAINABILITY AND REGULATORY LANDSCAPE 89 7.1 REGIONAL REGULATIONS AND COMPLIANCE 89 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 7.1.2 INDUSTRY STANDARDS 91 7.2 SUSTAINABILITY INITIATIVES 91 7.2.1 ENVIRONMENTAL IMPACT AND ECO-FRIENDLY INITIATIVES IN SURGICAL GOWNS AND DRAPES 91 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 93 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 94 8.1 DECISION-MAKING PROCESS 94 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 94 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 94 8.2.2 BUYING CRITERIA 95 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 96 8.4 UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 97 8.5 MARKET PROFITABILITY 98 8.5.1 REVENUE POTENTIAL 98 8.5.2 COST DYNAMICS 98 8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 98 9 SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE 100 9.1 INTRODUCTION 101 9.2 SURGICAL DRAPES 101 9.2.1 DISPOSABLE DRAPES 105 9.2.1.1 Increasing volume of surgeries and growing focus on infection prevention to drive market 105 9.2.2 REUSABLE DRAPES 107 9.2.2.1 Durability and sustainability to contribute to growth 107 9.3 SURGICAL GOWNS 110 9.3.1 USAGE PATTERN 114 9.3.1.1 Disposable gowns 114 9.3.1.1.1 Convenience and single-use nature to foster growth 114 9.3.1.2 Reusable gowns 117 9.3.1.2.1 Long-term cost-effectiveness to encourage growth 117 9.3.2 TYPE 120 9.3.2.1 Standard performance gowns 121 9.3.2.1.1 Increasing use of standard performance gowns in low-risk procedures to favor growth 121 9.3.2.2 Reinforced gowns 123 9.3.2.2.1 Rising demand for reinforced gowns to protect healthcare workers during moderate-risk surgical procedures to boost market 123 9.3.2.3 High-performance gowns 126 9.3.2.3.1 Lightweight and breathable properties to accelerate growth 126 10 SURGICAL GOWNS AND DRAPES MARKET: VOLUME ANALYSIS 129 10.1 INTRODUCTION 129 10.1.1 US: TOTAL VOLUME OF SURGICAL DRAPES, BY APPLICATION, 2023–2030 (MILLION UNITS) 129 10.1.2 US: TOTAL VOLUME OF SURGICAL GOWNS, BY APPLICATION, 2023–2030 (MILLION UNITS) 130 11 SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL 131 11.1 INTRODUCTION 132 11.2 NON-WOVEN MATERIALS 133 11.2.1 POLYPROPYLENE (PP) 135 11.2.1.1 Ability to offer varying degrees of fluid resistance, breathability, and comfort to fuel market 135 11.2.2 POLYETHYLENE (PE) 138 11.2.2.1 Low-friction surface and ease of manufacturing to spur growth 138 11.2.3 SPUNBOND-MELTBLOWN-SPUNBOND (SMS) 140 11.2.3.1 Enhanced durability and resistance to stimulate growth 140 11.2.4 SPUNLACE MATERIALS 143 11.2.4.1 Growing adoption of non-wovens in single-use medical barriers to drive market 143 11.2.5 OTHER NON-WOVEN MATERIALS 146 11.3 WOVEN FABRICS 149 11.3.1 COTTON 152 11.3.1.1 Improved air circulation and compatibility with sensitive skin to boost market 152 11.3.2 POLYESTER-COTTON BLENDS 154 11.3.2.1 Higher resistance to wrinkles, abrasion, and shrinkage to aid growth 154 11.3.3 POLYESTER 157 11.3.3.1 High level of structural integrity to favor growth 157 11.3.4 MICROFIBER FABRICS 159 11.3.4.1 Growing patient volume to drive market 159 11.3.5 LAMINATED/COATED MATERIALS 162 11.3.5.1 Enhanced protective qualities and durability to promote growth 162 11.4 BIODEGRADABLE MATERIALS 165 11.4.1 RISING GERIATRIC POPULATION AND HIGH INCIDENCE OF EPILEPSY TO DRIVE MARKET 165   12 SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY 168 12.1 INTRODUCTION 169 12.2 STERILE PRODUCTS 169 12.2.1 INCREASING FOCUS ON REDUCING RISK OF INFECTIONS TO AID GROWTH 169 12.3 NON-STERILE PRODUCTS 172 12.3.1 RISING POPULARITY IN PATIENT WARDS AND EMERGENCY ROOMS TO EXPEDITE GROWTH 172 13 SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION 176 13.1 INTRODUCTION 177 13.2 CARDIOVASCULAR APPLICATIONS 177 13.2.1 GROWING INCIDENCE OF CARDIOVASCULAR DISEASES TO FUEL MARKET 177 13.3 GENERAL SURGERY 180 13.3.1 INCREASING VOLUME OF GENERAL SURGERIES TO SPUR GROWTH 180 13.4 GYNECOLOGY 182 13.4.1 RISING C-SECTION AND HYSTERECTOMY CASES TO BOLSTER GROWTH 182 13.5 OPHTHALMOLOGY 185 13.5.1 INCREASING PREVALENCE OF EYE CONDITIONS TO AID GROWTH 185 13.6 LITHOTOMY & LAPAROSCOPY 187 13.6.1 QUICK RECOVERY TIMES AND REDUCED COMPLICATIONS TO FACILITATE GROWTH 187 13.7 OTHER APPLICATIONS 190 14 SURGICAL GOWNS AND DRAPES MARKET, BY END USER 194 14.1 INTRODUCTION 195 14.2 HOSPITALS 195 14.2.1 INCREASING NUMBER OF SURGERIES PERFORMED GLOBALLY TO PROMOTE GROWTH 195 14.3 AMBULATORY SURGICAL CENTERS 198 14.3.1 RISING FOCUS ON IMPROVED CARE QUALITY AND REDUCED PROCEDURAL COSTS TO BOOST MARKET 198 14.4 OTHER END USERS 201 15 SURGICAL GOWNS AND DRAPES MARKET, BY REGION 204 15.1 INTRODUCTION 205 15.2 NORTH AMERICA 205 15.2.1 US 210 15.2.1.1 Growing cases of healthcare-associated infections to drive market 210 15.2.2 CANADA 213 15.2.2.1 Rising geriatric population to support growth 213   15.3 EUROPE 217 15.3.1 GERMANY 221 15.3.1.1 Growing adoption of hospital disinfection and surveillance systems to boost market 221 15.3.2 UK 226 15.3.2.1 Increasing focus on comprehensive, data-driven infection control strategies to fuel market 226 15.3.3 FRANCE 230 15.3.3.1 Stringent regulatory guidelines for infection control product commercialization to aid growth 230 15.3.4 ITALY 233 15.3.4.1 Increasing establishment of long-term care facilities to boost market 233 15.3.5 SPAIN 237 15.3.5.1 Increasing incidence of chronic diseases to spur growth 237 15.3.6 REST OF EUROPE 241 15.4 ASIA PACIFIC 245 15.4.1 JAPAN 250 15.4.1.1 Increasing elderly population and healthcare expenditure to drive market 250 15.4.2 CHINA 254 15.4.2.1 Rising healthcare spending and increasing prevalence of chronic diseases to drive market 254 15.4.3 INDIA 257 15.4.3.1 Extensive patient population to contribute to growth 257 15.4.4 AUSTRALIA 262 15.4.4.1 Increasing demand for healthcare services to facilitate growth 262 15.4.5 REST OF ASIA PACIFIC 266 15.5 LATIN AMERICA 270 15.5.1 BRAZIL 274 15.5.1.1 Robust pharmaceutical and biotechnology industries to drive market 274 15.5.2 MEXICO 278 15.5.2.1 Changing demographic trend to encourage growth 278 15.5.3 REST OF LATIN AMERICA 281 15.6 MIDDLE EAST & AFRICA 286 16 COMPETITIVE LANDSCAPE 290 16.1 OVERVIEW 290 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 290 16.3 REVENUE ANALYSIS, 2022–2024 291 16.4 MARKET SHARE ANALYSIS, 2024 292 16.5 BRAND/PRODUCT COMPARISON 295 16.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 295 16.6.1 STARS 296 16.6.2 EMERGING LEADERS 296 16.6.3 PERVASIVE PLAYERS 296 16.6.4 PARTICIPANTS 296 16.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 298 16.6.5.1 Company footprint 298 16.6.5.2 Region footprint 299 16.6.5.3 Product type footprint 300 16.6.5.4 Application footprint 301 16.6.5.5 End-user footprint 302 16.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 303 16.7.1 PROGRESSIVE COMPANIES 303 16.7.2 RESPONSIVE COMPANIES 303 16.7.3 DYNAMIC COMPANIES 303 16.7.4 STARTING BLOCKS 303 16.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 305 16.7.5.1 Detailed list of key startups/SMEs 305 16.7.5.2 Competitive benchmarking of key startups/SMEs 306 16.8 COMPANY VALUATION AND FINANCIAL METRICS 307 16.9 COMPETITIVE SCENARIO 308 16.9.1 PRODUCT LAUNCHES AND APPROVALS 308 16.9.2 DEALS 308 16.9.3 EXPANSIONS 309 16.9.4 OTHER DEVELOPMENTS 310 17 COMPANY PROFILES 311 17.1 KEY PLAYERS 311 17.1.1 CARDINAL HEALTH 311 17.1.1.1 Business overview 311 17.1.1.2 Products offered 312 17.1.1.3 Recent developments 313 17.1.1.3.1 Product launches and approvals 313 17.1.1.3.2 Expansions 314 17.1.1.4 MnM view 314 17.1.1.4.1 Key strengths/Right to win 314 17.1.1.4.2 Strategic choices 314 17.1.1.4.3 Weaknesses/Competitive threats 314 17.1.2 MEDLINE INDUSTRIES, LP 315 17.1.2.1 Business overview 315 17.1.2.2 Products offered 315 17.1.2.3 Recent developments 317 17.1.2.3.1 Deals 317 17.1.2.3.2 Other developments 317 17.1.2.4 MnM view 317 17.1.2.4.1 Key strengths/Right to win 317 17.1.2.4.2 Strategic choices 317 17.1.2.4.3 Weaknesses/Competitive threats 318 17.1.3 OWENS & MINOR 319 17.1.3.1 Business overview 319 17.1.3.2 Products offered 321 17.1.3.3 MnM view 322 17.1.3.3.1 Key strengths/Right to win 322 17.1.3.3.2 Strategic choices 322 17.1.3.3.3 Weaknesses/Competitive threats 322 17.1.4 MCKESSON CORPORATION 323 17.1.4.1 Business overview 323 17.1.4.2 Products offered 324 17.1.4.3 MnM view 325 17.1.4.3.1 Key strengths/Right to win 325 17.1.4.3.2 Strategic choices 325 17.1.4.3.3 Weaknesses/Competitive threats 325 17.1.5 MÖLNLYCKE AB 326 17.1.5.1 Business overview 326 17.1.5.2 Products offered 327 17.1.5.3 MnM view 328 17.1.5.3.1 Key strengths/Right to win 328 17.1.5.3.2 Strategic choices 328 17.1.5.3.3 Weaknesses/Competitive threats 328 17.1.6 SOLVENTUM 329 17.1.6.1 Business overview 329 17.1.6.2 Products offered 330 17.1.6.3 Recent developments 331 17.1.6.3.1 Other developments 331 17.1.7 PAUL HARTMANN AG 332 17.1.7.1 Business overview 332 17.1.7.2 Products offered 333 17.1.7.3 Recent developments 334 17.1.7.3.1 Deals 334 17.1.8 WINNER MEDICAL, CO., LTD. 335 17.1.8.1 Business overview 335 17.1.8.2 Products offered 337 17.1.8.3 Recent developments 337 17.1.8.3.1 Deals 337 17.1.9 STERIS 339 17.1.9.1 Business overview 339 17.1.9.2 Products offered 340 17.1.10 ALPHAPROTECH 341 17.1.10.1 Business overview 341 17.1.10.2 Products offered 342 17.1.11 HENRY SCHEIN 343 17.1.11.1 Business overview 343 17.1.11.2 Products offered 344 17.1.12 B.BRAUN SE 345 17.1.12.1 Business overview 345 17.1.12.2 Products offered 346 17.1.13 BOSTON SCIENTIFIC CORPORATION 347 17.1.13.1 Business overview 347 17.1.13.2 Products offered 348 17.2 OTHER PLAYERS 349 17.2.1 LOHMANN & RAUSCHER GMBH & CO. KG 349 17.2.2 STANDARD TEXTILE CO., INC. 350 17.2.3 PLURITEX S.R.L. 351 17.2.4 MEDICA EUROPE BV 352 17.2.5 AMARYLLIS HEALTHCARE PVT. LTD. 353 17.2.6 STERIMED GROUP 354 17.2.7 GPC MEDICAL 355 17.2.8 ALLESET 356 17.2.9 BOEN HEALTHCARE CO., LTD. 357 17.2.10 PRIONTEX 358 17.2.11 EURONDA SPA 359 17.2.12 TIDI PRODUCTS, LLC. 360 18 RESEARCH METHODOLOGY 361 18.1 RESEARCH DATA 361 18.1.1 SECONDARY DATA 362 18.1.1.1 List of secondary sources 362 18.1.1.2 Key data from secondary sources 362 18.1.2 PRIMARY DATA 363 18.1.2.1 List of primary sources 363 18.1.2.2 Key data from primary sources 364 18.1.2.3 Breakdown of primary interviews 365 18.1.2.4 Key industry insights 365 18.2 MARKET SIZE ESTIMATION 366 18.2.1 BOTTOM-UP APPROACH 366 18.2.1.1 Approach 1: Revenue estimation of key players 366 18.2.1.2 Approach 2: Study of annual reports and investor presentations 366 18.2.1.3 Approach 3: Primary interviews 367 18.2.1.4 Growth forecast 367 18.2.1.5 CAGR projections 367 18.2.2 TOP-DOWN APPROACH 368 18.3 DATA TRIANGULATION 369 18.4 RESEARCH ASSUMPTIONS 369 18.4.1 STUDY-RELATED ASSUMPTIONS 369 18.4.2 PARAMETRIC ASSUMPTIONS 370 18.4.3 GROWTH RATE ASSUMPTIONS 371 18.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 371 18.5.1 RESEARCH LIMITATIONS 371 18.5.2 RISK ASSESSMENT 371 19 APPENDIX 372 19.1 DISCUSSION GUIDE 372 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 375 19.3 CUSTOMIZATION OPTIONS 377 19.4 RELATED REPORTS 377 19.5 AUTHOR DETAILS 378
圖表清單 List of Tables & Figures
TABLE 1 SURGICAL DRAPES AND GOWNS MARKET: INCLUSIONS AND EXCLUSIONS 37 TABLE 2 EUROPE: PREVALENCE OF HEALTHCARE-ASSOCIATED INFECTIONS IN ACUTE CARE HOSPITALS, BY TYPE, 2022–2023 49 TABLE 3 GERMANY: SURGERY TYPES FOR INPATIENT HOSPITAL VISITS, 2023 51 TABLE 4 IMPACT OF PORTER’S FORCES ON SURGICAL GOWNS AND DRAPES MARKET 60 TABLE 5 GDP PERCENTAGE CHANGE (%), BY KEY COUNTRY, 2023–2030 61 TABLE 6 NORTH AMERICA: MACROECONOMIC INDICATORS 62 TABLE 7 EUROPE: MACROECONOMIC INDICATORS 63 TABLE 8 ASIA PACIFIC: MACROECONOMIC INDICATORS 63 TABLE 9 LATIN AMERICA: MACROECONOMIC INDICATORS 63 TABLE 10 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 63 TABLE 11 SURGICAL GOWNS AND DRAPES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 67 TABLE 12 AVERAGE SELLING PRICING TREND OF SURGICAL GOWNS AND DRAPES, BY PRODUCT, 2023–2025 (USD) 68 TABLE 13 AVERAGE SELLING PRICE TREND OF SURGICAL GOWNS, BY KEY PLAYER, 2023–2025 (USD) 69 TABLE 14 AVERAGE SELLING PRICE TREND OF SURGICAL GOWNS AND DRAPES PRODUCTS, BY REGION, 2023–2025 (USD) 70 TABLE 15 IMPORT DATA FOR HS CODE 621010-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 70 TABLE 16 EXPORT DATA FOR HS CODE 621010-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 71 TABLE 17 SURGICAL GOWNS AND DRAPES MARKET: KEY CONFERENCES AND EVENTS, 2025–2027 71 TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES 76 TABLE 19 SURGICAL GOWNS AND DRAPES MARKET: LIST OF MAJOR PATENTS, 2023–2025 85 TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 24 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 25 GLOBAL STANDARDS IN SURGICAL GOWNS AND DRAPES MARKET 91 TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE (%) 95 TABLE 27 KEY BUYING CRITERIA, BY PRODUCT TYPE 95 TABLE 28 ADOPTION BARRIERS AND INTERNAL CHALLENGES 96 TABLE 29 SURGICAL GOWNS AND DRAPES MARKET: UNMET NEEDS IN VARIOUS END-USE INDUSTRIES 97 TABLE 30 SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 101 TABLE 31 SURGICAL DRAPES OFFERED BY MAJOR COMPANIES 102 TABLE 32 SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 102 TABLE 33 SURGICAL DRAPES MARKET, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 34 NORTH AMERICA: SURGICAL DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 35 EUROPE: SURGICAL DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 36 ASIA PACIFIC: SURGICAL DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 37 LATIN AMERICA: SURGICAL DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 38 SURGICAL DRAPES MARKET FOR DISPOSABLE DRAPES, BY REGION, 2023–2030 (USD MILLION) 105 TABLE 39 NORTH AMERICA: SURGICAL DRAPES MARKET FOR DISPOSABLE DRAPES, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 40 EUROPE: SURGICAL DRAPES MARKET FOR DISPOSABLE DRAPES, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 41 ASIA PACIFIC: SURGICAL DRAPES MARKET FOR DISPOSABLE DRAPES, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 42 LATIN AMERICA: SURGICAL DRAPES MARKET FOR DISPOSABLE DRAPES, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 43 SURGICAL DRAPES MARKET FOR REUSABLE DRAPES, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 44 NORTH AMERICA: SURGICAL DRAPES MARKET FOR REUSABLE DRAPES, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 45 EUROPE: SURGICAL DRAPES MARKET FOR REUSABLE DRAPES, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 46 ASIA PACIFIC: SURGICAL DRAPES MARKET FOR REUSABLE DRAPES, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 47 LATIN AMERICA: SURGICAL DRAPES MARKET FOR REUSABLE DRAPES, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 48 LEVELS OF SURGICAL GOWNS 111 TABLE 49 SURGICAL GOWNS OFFERED BY MAJOR COMPANIES 111 TABLE 50 SURGICAL GOWNS MARKET, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 51 NORTH AMERICA: SURGICAL GOWNS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 52 EUROPE: SURGICAL GOWNS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 53 ASIA PACIFIC: SURGICAL GOWNS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 54 LATIN AMERICA: SURGICAL GOWNS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 55 SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 114 TABLE 56 SURGICAL GOWNS MARKET FOR DISPOSABLE GOWNS, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 57 NORTH AMERICA: SURGICAL GOWNS MARKET FOR DISPOSABLE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 58 EUROPE: SURGICAL GOWNS MARKET FOR DISPOSABLE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 59 ASIA PACIFIC: SURGICAL GOWNS MARKET FOR DISPOSABLE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 60 LATIN AMERICA: SURGICAL GOWNS MARKET FOR DISPOSABLE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 61 SURGICAL GOWNS MARKET FOR REUSABLE GOWNS, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 62 NORTH AMERICA: SURGICAL GOWNS MARKET FOR REUSABLE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 63 EUROPE: SURGICAL GOWNS MARKET FOR REUSABLE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 64 ASIA PACIFIC: SURGICAL GOWNS MARKET FOR REUSABLE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 65 LATIN AMERICA: SURGICAL GOWNS MARKET FOR REUSABLE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 66 SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 120 TABLE 67 SURGICAL GOWNS MARKET FOR STANDARD PERFORMANCE GOWNS, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 68 NORTH AMERICA: SURGICAL GOWNS MARKET FOR STANDARD PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 69 EUROPE: SURGICAL GOWNS MARKET FOR STANDARD PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 70 ASIA PACIFIC: SURGICAL GOWNS MARKET FOR STANDARD PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 71 LATIN AMERICA: SURGICAL GOWNS MARKET FOR STANDARD PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 72 SURGICAL GOWNS MARKET FOR REINFORCED GOWNS, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 73 NORTH AMERICA: SURGICAL GOWNS MARKET FOR REINFORCED GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 74 EUROPE: SURGICAL GOWNS MARKET FOR REINFORCED GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 75 ASIA PACIFIC: SURGICAL GOWNS MARKET FOR REINFORCED GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 76 LATIN AMERICA: SURGICAL GOWNS MARKET FOR REINFORCED GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 77 SURGICAL GOWNS MARKET FOR HIGH-PERFORMANCE GOWNS, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 78 NORTH AMERICA: SURGICAL GOWNS MARKET FOR HIGH-PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 79 EUROPE: SURGICAL GOWNS MARKET FOR HIGH-PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 80 ASIA PACIFIC: SURGICAL GOWNS MARKET FOR HIGH-PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 81 LATIN AMERICA: SURGICAL GOWNS MARKET FOR HIGH-PERFORMANCE GOWNS, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 82 VOLUME OF SURGICAL DRAPES IN THE US, BY APPLICATION 2023–2030 (MILLION UNITS) 129 TABLE 83 VOLUME OF SURGICAL GOWNS IN THE US, BY APPLICATION 2023–2030 (MILLION UNITS) 130 TABLE 84 SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 132 TABLE 85 SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 86 SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 87 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 88 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 89 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 90 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 91 SURGICAL GOWNS AND DRAPES MARKET FOR POLYPROPYLENE, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 92 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYPROPYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 93 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR POLYPROPYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 94 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR POLYPROPYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 95 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYPROPYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 96 SURGICAL GOWNS AND DRAPES MARKET FOR POLYETHYLENE, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 97 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYETHYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 98 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR POLYETHYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 99 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR POLYETHYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 100 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYETHYLENE, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 101 SURGICAL GOWNS AND DRAPES MARKET FOR SPUNBOND-MELTBLOWN-SPUNBOND MATERIALS, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 102 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNBOND-MELTBLOWN-SPUNBOND MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 103 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNBOND-MELTBLOWN-SPUNBOND MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 104 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNBOND-MELTBLOWN-SPUNBOND MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 105 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNBOND-MELTBLOWN-SPUNBOND MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 106 SURGICAL GOWNS AND DRAPES MARKET FOR SPUNLACE MATERIALS, BY REGION, 2023–2030 (USD MILLION) 144 TABLE 107 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNLACE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 108 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNLACE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 109 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNLACE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 110 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR SPUNLACE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 111 SURGICAL GOWNS AND DRAPES MARKET FOR OTHER NON-WOVEN MATERIALS, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 112 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 113 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 114 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 115 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER NON-WOVEN MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 116 SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 117 SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 118 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 119 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 120 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 121 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR WOVEN FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 122 SURGICAL GOWNS AND DRAPES MARKET FOR COTTON, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 123 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR COTTON, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 124 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR COTTON, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 125 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR COTTON, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 126 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR COTTON, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 127 SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER-COTTON BLENDS, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 128 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER-COTTON BLENDS, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 129 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER-COTTON BLENDS, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 130 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER-COTTON BLENDS, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 131 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER-COTTON BLENDS, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 132 SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 133 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 134 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 135 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 136 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR POLYESTER, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 137 SURGICAL GOWNS AND DRAPES MARKET FOR MICROFIBER FABRICS, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 138 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR MICROFIBER FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 139 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR MICROFIBER FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 140 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR MICROFIBER FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 141 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR MICROFIBER FABRICS, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 142 SURGICAL GOWNS AND DRAPES MARKET FOR LAMINATED/COATED MATERIALS, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 143 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR LAMINATED/COATED MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 144 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR LAMINATED/COATED MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 145 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR LAMINATED/COATED MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 146 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR LAMINATED/COATED MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 147 SURGICAL GOWNS AND DRAPES MARKET FOR BIODEGRADABLE MATERIALS, BY REGION, 2023–2030 (USD MILLION) 165 TABLE 148 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR BIODEGRADABLE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 149 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR BIODEGRADABLE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 150 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR BIODEGRADABLE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 151 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR BIODEGRADABLE MATERIALS, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 152 SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 169 TABLE 153 SURGICAL GOWNS AND DRAPES MARKET FOR STERILE PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 154 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 155 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 156 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 157 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 158 SURGICAL GOWNS AND DRAPES MARKET FOR NON-STERILE PRODUCTS, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 159 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR NON-STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 160 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR NON-STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 161 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR NON-STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 162 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR NON-STERILE PRODUCTS, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 163 SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 177 TABLE 164 SURGICAL GOWNS AND DRAPES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 178 TABLE 165 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 166 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 167 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 168 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 169 SURGICAL GOWNS AND DRAPES MARKET FOR GENERAL SURGERY, BY REGION, 2023–2030 (USD MILLION) 180 TABLE 170 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR GENERAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 171 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR GENERAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 172 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR GENERAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 173 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR GENERAL SURGERY, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 174 SURGICAL GOWNS AND DRAPES MARKET FOR GYNECOLOGY, BY REGION, 2023–2030 (USD MILLION) 183 TABLE 175 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR GYNECOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 176 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR GYNECOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 177 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR GYNECOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 178 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR GYNECOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 179 SURGICAL GOWNS AND DRAPES MARKET FOR OPHTHALMOLOGY, BY REGION, 2023–2030 (USD MILLION) 185 TABLE 180 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 181 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 182 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 183 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 184 SURGICAL GOWNS AND DRAPES MARKET FOR LITHOTOMY & LAPAROSCOPY, BY REGION, 2023–2030 (USD MILLION) 188 TABLE 185 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR LITHOTOMY & LAPAROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 188 TABLE 186 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR LITHOTOMY & LAPAROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 187 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR LITHOTOMY & LAPAROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 188 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR LITHOTOMY & LAPAROSCOPY, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 189 SURGICAL GOWNS AND DRAPES MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 191 TABLE 190 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 191 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 192 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 193 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 194 SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 195 TABLE 195 SURGICAL GOWNS AND DRAPES MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 196 TABLE 196 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 197 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 198 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 199 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 200 SURGICAL GOWNS AND DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2023–2030 (USD MILLION) 199 TABLE 201 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 202 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 203 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 204 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 205 SURGICAL GOWNS AND DRAPES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 201 TABLE 206 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 207 EUROPE: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 208 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 209 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 210 SURGICAL GOWNS AND DRAPES MARKET, BY REGION, 2023–2030 (USD MILLION) 205 TABLE 211 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 212 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 207 TABLE 213 NORTH AMERICA: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 207 TABLE 214 NORTH AMERICA: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 208 TABLE 215 NORTH AMERICA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 216 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 208 TABLE 217 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 209 TABLE 218 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 209 TABLE 219 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 210 TABLE 220 US: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 211 TABLE 221 US: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 211 TABLE 222 US: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 211 TABLE 223 US: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 224 US: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 212 TABLE 225 US: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 212 TABLE 226 US: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 213 TABLE 227 US: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 213 TABLE 228 CANADA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 214 TABLE 229 CANADA: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 215 TABLE 230 CANADA: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 215 TABLE 231 CANADA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 232 CANADA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 216 TABLE 233 CANADA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 216 TABLE 234 CANADA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 217 TABLE 235 CANADA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 217 TABLE 236 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 237 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 218 TABLE 238 EUROPE: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 219 TABLE 239 EUROPE: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 219 TABLE 240 EUROPE: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 241 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 220 TABLE 242 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 220 TABLE 243 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 221 TABLE 244 EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 221 TABLE 245 GERMANY: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 222 TABLE 246 GERMANY: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 223 TABLE 247 GERMANY: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 223 TABLE 248 GERMANY: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 249 GERMANY: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 224 TABLE 250 GERMANY: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 224 TABLE 251 GERMANY: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 225 TABLE 252 GERMANY: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 225 TABLE 253 UK: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 227 TABLE 254 UK: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 227 TABLE 255 UK: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 227 TABLE 256 UK: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 257 UK: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 228 TABLE 258 UK: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 228 TABLE 259 UK: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 229 TABLE 260 UK: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 229 TABLE 261 FRANCE: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 231 TABLE 262 FRANCE: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 231 TABLE 263 FRANCE: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 231 TABLE 264 FRANCE: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 265 FRANCE: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 232 TABLE 266 FRANCE: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 232 TABLE 267 FRANCE: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 233 TABLE 268 FRANCE: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 233 TABLE 269 ITALY: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 234 TABLE 270 ITALY: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 234 TABLE 271 ITALY: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 235 TABLE 272 ITALY: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 273 ITALY: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 235 TABLE 274 ITALY: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 236 TABLE 275 ITALY: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 236 TABLE 276 ITALY: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 237 TABLE 277 SPAIN: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 238 TABLE 278 SPAIN: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 238 TABLE 279 SPAIN: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 238 TABLE 280 SPAIN: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 281 SPAIN: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 239 TABLE 282 SPAIN: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 239 TABLE 283 SPAIN: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 240 TABLE 284 SPAIN: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 240 TABLE 285 REST OF EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 242 TABLE 286 REST OF EUROPE: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 242 TABLE 287 REST OF EUROPE: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 243 TABLE 288 REST OF EUROPE: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 289 REST OF EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 243 TABLE 290 REST OF EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 244 TABLE 291 REST OF EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 244 TABLE 292 REST OF EUROPE: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 245 TABLE 293 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 294 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 247 TABLE 295 ASIA PACIFIC: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 247 TABLE 296 ASIA PACIFIC: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 247 TABLE 297 ASIA PACIFIC: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 298 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 248 TABLE 299 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 248 TABLE 300 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 249 TABLE 301 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 249 TABLE 302 JAPAN: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 250 TABLE 303 JAPAN: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 251 TABLE 304 JAPAN: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 251 TABLE 305 JAPAN: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 306 JAPAN: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 252 TABLE 307 JAPAN: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 252 TABLE 308 JAPAN: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 253 TABLE 309 JAPAN: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 253 TABLE 310 CHINA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 254 TABLE 311 CHINA: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 255 TABLE 312 CHINA: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 255 TABLE 313 CHINA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 314 CHINA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 256 TABLE 315 CHINA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 256 TABLE 316 CHINA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 257 TABLE 317 CHINA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 257 TABLE 318 INDIA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 258 TABLE 319 INDIA: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 259 TABLE 320 INDIA: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 259 TABLE 321 INDIA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 322 INDIA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 260 TABLE 323 INDIA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 260 TABLE 324 INDIA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 261 TABLE 325 INDIA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 261 TABLE 326 AUSTRALIA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 263 TABLE 327 AUSTRALIA: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 263 TABLE 328 AUSTRALIA: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 263 TABLE 329 AUSTRALIA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 330 AUSTRALIA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 264 TABLE 331 AUSTRALIA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 264 TABLE 332 AUSTRALIA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 265 TABLE 333 AUSTRALIA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 265 TABLE 334 REST OF ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 266 TABLE 335 REST OF ASIA PACIFIC: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 267 TABLE 336 REST OF ASIA PACIFIC: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 267 TABLE 337 REST OF ASIA PACIFIC: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 338 REST OF ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 268 TABLE 339 REST OF ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 268 TABLE 340 REST OF ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 269 TABLE 341 REST OF ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 269 TABLE 342 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 270 TABLE 343 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 271 TABLE 344 LATIN AMERICA: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 271 TABLE 345 LATIN AMERICA: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 271 TABLE 346 LATIN AMERICA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 347 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 272 TABLE 348 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 272 TABLE 349 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 273 TABLE 350 LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 273 TABLE 351 BRAZIL: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 274 TABLE 352 BRAZIL: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 275 TABLE 353 BRAZIL: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 275 TABLE 354 BRAZIL: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 355 BRAZIL: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 276 TABLE 356 BRAZIL: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 276 TABLE 357 BRAZIL: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 277 TABLE 358 BRAZIL: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 277 TABLE 359 MEXICO: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 278 TABLE 360 MEXICO: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 279 TABLE 361 MEXICO: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 279 TABLE 362 MEXICO: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 363 MEXICO: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 280 TABLE 364 MEXICO: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 280 TABLE 365 MEXICO: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 281 TABLE 366 MEXICO: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 281 TABLE 367 REST OF LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 282 TABLE 368 REST OF LATIN AMERICA: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 283 TABLE 369 REST OF LATIN AMERICA: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 283 TABLE 370 REST OF LATIN AMERICA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 371 REST OF LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 284 TABLE 372 REST OF LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 284 TABLE 373 REST OF LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 285 TABLE 374 REST OF LATIN AMERICA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 285 TABLE 375 MIDDLE EAST & AFRICA: SURGICAL GOWNS AND DRAPES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 286 TABLE 376 MIDDLE EAST & AFRICA: SURGICAL DRAPES MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 287 TABLE 377 MIDDLE EAST & AFRICA: SURGICAL GOWNS MARKET, BY USAGE PATTERN, 2023–2030 (USD MILLION) 287 TABLE 378 MIDDLE EAST & AFRICA: SURGICAL GOWNS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 379 MIDDLE EAST & AFRICA: SURGICAL GOWNS AND DRAPES MARKET, BY MATERIAL, 2023–2030 (USD MILLION) 288 TABLE 380 MIDDLE EAST & AFRICA: SURGICAL GOWNS AND DRAPES MARKET, BY STERILITY, 2023–2030 (USD MILLION) 288 TABLE 381 MIDDLE EAST & AFRICA: SURGICAL GOWNS AND DRAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 289 TABLE 382 MIDDLE EAST & AFRICA: SURGICAL GOWNS AND DRAPES MARKET, BY END USER, 2023–2030 (USD MILLION) 289 TABLE 383 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025 290 TABLE 384 SURGICAL GOWNS AND DRAPES MARKET: DEGREE OF COMPETITION 293 TABLE 385 SURGICAL GOWNS AND DRAPES MARKET: REGION FOOTPRINT 299 TABLE 386 SURGICAL GOWNS AND DRAPES MARKET: PRODUCT TYPE FOOTPRINT 300 TABLE 387 SURGICAL GOWNS AND DRAPES MARKET: APPLICATION FOOTPRINT 301 TABLE 388 SURGICAL GOWNS AND DRAPES MARKET: END-USER FOOTPRINT 302 TABLE 389 SURGICAL GOWNS AND DRAPES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 305 TABLE 390 SURGICAL GOWNS AND DRAPES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 306 TABLE 391 SURGICAL GOWNS AND DRAPES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025 308 TABLE 392 SURGICAL GOWNS AND DRAPES MARKET: DEALS, JANUARY 2022–OCTOBER 2025 308 TABLE 393 SURGICAL GOWNS AND DRAPES MARKET: EXPANSIONS, JANUARY 2022–OCTOBER 2025 309 TABLE 394 SURGICAL GOWNS AND DRAPES MARKET: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025 310 TABLE 395 CARDINAL HEALTH: COMPANY OVERVIEW 311 TABLE 396 CARDINAL HEALTH: PRODUCTS OFFERED 312 TABLE 397 CARDINAL HEALTH: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025 313 TABLE 398 CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–OCTOBER 2025 314 TABLE 399 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 315 TABLE 400 MEDLINE INDUSTRIES, LP.: PRODUCTS OFFERED 315 TABLE 401 MEDLINE INDUSTRIES, LP: DEALS, JANUARY 2022– OCTOBER 2025 317 TABLE 402 MEDLINE INDUSTRIES, LP: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025 317 TABLE 403 OWENS & MINOR: COMPANY OVERVIEW 319 TABLE 404 OWENS & MINOR: PRODUCTS OFFERED 321 TABLE 405 MCKESSON CORPORATION: COMPANY OVERVIEW 323 TABLE 406 MCKESSON CORPORATION: PRODUCTS OFFERED 324 TABLE 407 MÖLNLYCKE AB: COMPANY OVERVIEW 326 TABLE 408 MÖLNLYCKE AB: PRODUCTS OFFERED 327 TABLE 409 SOLVENTUM: COMPANY OVERVIEW 329 TABLE 410 SOLVENTUM: PRODUCTS OFFERED 330 TABLE 411 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025 331 TABLE 412 PAUL HARTMANN AG: COMPANY OVERVIEW 332 TABLE 413 PAUL HARTMANN AG: PRODUCTS OFFERED 333 TABLE 414 PAUL HARTMANN AG: DEALS, JANUARY 2022– OCTOBER 2025 334 TABLE 415 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW 335 TABLE 416 WINNER MEDICAL CO., LTD.: PRODUCTS OFFERED 337 TABLE 417 WINNER MEDICAL: DEALS, JANUARY 2022– OCTOBER 2025 337 TABLE 418 STERIS: COMPANY OVERVIEW 339 TABLE 419 STERIS: PRODUCTS OFFERED 340 TABLE 420 ALPHAPROTECH: COMPANY OVERVIEW 341 TABLE 421 ALPHAPROTECH: PRODUCTS OFFERED 342 TABLE 422 HENRY SCHEIN: COMPANY OVERVIEW 343 TABLE 423 HENRY SCHEIN: PRODUCTS OFFERED 344 TABLE 424 B. BRAUN SE: COMPANY OVERVIEW 345 TABLE 425 B. BRAUN SE: PRODUCTS OFFERED 346 TABLE 426 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 347 TABLE 427 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 348 TABLE 428 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 349 TABLE 429 STANDARD TEXTILE CO., INC.: COMPANY OVERVIEW 350 TABLE 430 PLURITEX S.R.L.: COMPANY OVERVIEW 351 TABLE 431 MEDICA EUROPE BV: COMPANY OVERVIEW 352 TABLE 432 AMARYLLIS HEALTHCARE PVT. LTD.: COMPANY OVERVIEW 353 TABLE 433 STERIMED GROUP: COMPANY OVERVIEW 354 TABLE 434 GPC MEDICAL: COMPANY OVERVIEW 355 TABLE 435 ALLESET: COMPANY OVERVIEW 356 TABLE 436 BOEN HEALTHCARE CO., LTD.: COMPANY OVERVIEW 357 TABLE 437 PRIONTEX: COMPANY OVERVIEW 358 TABLE 438 EURONDA SPA: COMPANY OVERVIEW 359 TABLE 439 TIDI PRODUCTS, LLC.: COMPANY OVERVIEW 360 TABLE 440 SURGICAL GOWNS AND DRAPES MARKET: RESEARCH ASSUMPTIONS 370 TABLE 441 SURGICAL GOWNS AND DRAPES MARKET: RISK ASSESSMENT 371 FIGURE 1 SURGICAL GOWNS AND DRAPES MARKET COVERED AND REGIONAL SEGMENTATION 36 FIGURE 2 KEY INSIGHTS AND MARKET HIGHLIGHTS 40 FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL GOWNS AND DRAPES MARKET, 2022–2025 41 FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF SURGICAL GOWNS AND DRAPES MARKET 41 FIGURE 5 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN SURGICAL GOWNS AND DRAPES MARKET, 2024 42 FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 43 FIGURE 7 GROWING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET 44 FIGURE 8 SURGICAL DRAPE SEGMENT EXPECTED TO DOMINATE MARKET DURING FORECAST PERIOD 45 FIGURE 9 NON-WOVEN MATERIALS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 45 FIGURE 10 STERILE PRODUCTS SEGMENT TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD 46 FIGURE 11 GENERAL SURGERY SEGMENT TO HAVE LARGEST SHARE DURING FORECAST PERIOD 46 FIGURE 12 HOSPITALS SEGMENT TO COMMAND LARGEST SHARE DURING FORECAST PERIOD 47 FIGURE 13 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 47 FIGURE 14 SURGICAL GOWNS AND DRAPES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48 FIGURE 15 SURGICAL GOWNS AND DRAPES MARKET: PORTER’S FIVE FORCES ANALYSIS 59 FIGURE 16 SURGICAL GOWNS AND DRAPES MARKET: SUPPLY CHAIN ANALYSIS 65 FIGURE 17 SURGICAL GOWNS AND DRAPES MARKET: VALUE CHAIN ANALYSIS 66 FIGURE 18 SURGICAL GOWNS AND DRAPES MARKET: ECOSYSTEM ANALYSIS 67 FIGURE 19 SURGICAL GOWNS AND DRAPES MARKET: NEW REVENUE POCKETS FOR PLAYERS 72 FIGURE 20 SURGICAL GOWNS AND DRAPES MARKET: INVESTMENT AND FUNDING SCENARIO 73 FIGURE 21 PATENT ANALYSIS FOR SURGICAL GOWNS AND DRAPES, JANUARY 2015–DECEMBER 2024 84 FIGURE 22 MARKET POTENTIAL OF AI IN SURGICAL GOWNS AND DRAPES MARKET 87 FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 94 FIGURE 24 KEY BUYING CRITERIA, BY PRODUCT TYPE 95 FIGURE 25 NORTH AMERICA: SURGICAL GOWNS AND DRAPES MARKET SNAPSHOT 206 FIGURE 26 ASIA PACIFIC: SURGICAL GOWNS AND DRAPES MARKET SNAPSHOT 246 FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 291 FIGURE 28 GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 292 FIGURE 29 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 293 FIGURE 30 BRAND/PRODUCT COMPARISON 295 FIGURE 31 SURGICAL GOWNS AND DRAPES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 297 FIGURE 32 SURGICAL GOWNS AND DRAPES MARKET: COMPANY FOOTPRINT 298 FIGURE 33 SURGICAL GOWNS AND DRAPES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 304 FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF KEY VENDORS 307 FIGURE 35 EV/EBITDA OF KEY VENDORS 307 FIGURE 36 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 312 FIGURE 37 OWENS & MINOR: COMPANY SNAPSHOT (2024) 320 FIGURE 38 MCKESSON CORPORATION: COMPANY SNAPSHOT (2024) 323 FIGURE 39 MÖLNLYCKE AB: COMPANY SNAPSHOT (2024) 327 FIGURE 40 SOLVENTUM: COMPANY SNAPSHOT (2024) 330 FIGURE 41 PAUL HARTMANN AG: COMPANY SNAPSHOT (2024) 333 FIGURE 42 WINNER MEDICAL CO., LTD.: COMPANY SNAPSHOT (2023) 336 FIGURE 43 STERIS: COMPANY SNAPSHOT (2024) 340 FIGURE 44 ALPHAPROTECH: COMPANY SNAPSHOT (2024) 341 FIGURE 45 HENRY SCHEIN: COMPANY SNAPSHOT (2024) 344 FIGURE 46 B. BRAUN SE: COMPANY SNAPSHOT (2024) 346 FIGURE 47 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 348 FIGURE 48 RESEARCH DESIGN 361 FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 365 FIGURE 50 TOP-DOWN APPROACH 368 FIGURE 51 DATA TRIANGULATION 369

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們